drugset
drugset / Trial / NCT04867720

Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients

NCT04867720 ↗

Phase 4 Unknown 112 enrolled Chong Kun Dang Pharmaceutical
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy and safety of CertiroBell® tablet plus tacrolimus

Timeline

Start
2021-03-16
Primary completion
2022-10-10
Completion
2023-02-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule 1 mg Oral

Indications

No indication recorded.